Yann Mazabraud, EVP, Head of International at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 57,000 shares at $111.80 ($6.6M) on 2026-08-12, disclosed to the SEC on 2026-08-14.
Scheduled sale ($6.6M) by EVP, Head of International under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $111.80 | 2,300 | $257K | 3.9% |
| 2 | $112.86 | 1,000 | $113K | 1.7% |
| 3 | $114.70 | 3,605 | $413K | 6.2% |
| 4 | $115.43 | 14,568 | $1.7M | 25.4% |
| 5 | $116.49 | 18,208 | $2.1M | 32.0% |
| 6 | $117.47 | 17,319 |
| $2.0M |
| 30.7% |
| Total | $116.15 avg | 57,000 | $6.6M | 100% |
| Filing → |
| RYTM | SELL | 2025-03-18 | $7.7M | — | Filing → |
| RYTM | SELL | 2024-03-19 | $628K | — | Filing → |
| RYTM | SELL | 2024-02-13 | $211K | — | Filing → |